The Moyamoya Center

The Moyamoya Team

The Moyamoya Center at Stanford offers an extensively experienced group of professionals who see several new moyamoya patients each week. Since 1991, the Moyamoya Team, including neurosurgeons, neurologists, neuro-radiologists, neuro-anestheiologists, nurses, nurse practitioners, social workers, technologists, scheduling coordinators, office and clinic staff have enthusiastically worked with patients and families who traveled to the Bay Area from all over the world. The team approach we offer to patients and families is one of the main reasons patients feel they receive such excellent care.

Moyamoya Annual Picnic 2009

What is Moyamoya?

Moyamoya disease is a progressive disorder that affects the blood supply to the brain. It is rare, but is being detected more frequently with recent advances in diagnostic imaging. 

It can occur at any time, but is most commonly diagnosed in childhood between ages 5 - 15 and during adulthood between ages 30 - 40. 

History of Moyamoya

Moyamoya was first identified by the Japanese, who named it for the appearance of a puff of smoke that appeared on the cerebral angiogram. It is more common in Asians, but can affect any population.

Moyamoya disease is characterized by a progressive narrowing of the internal carotid arteries leading into the brain, and usually affects both sides of the brain.

The cause of arterial narrowing is unknown, but does not appear related to atherosclerosis or inflammation of the arteries.  

As the vessels narrow the brain receives less blood. 
This can result in temporary symptoms such as:

Dr. Steinberg with Stanford Moyamoya patient. Dr. Steinberg with Stanford Moyamoya patient.
Dr. Steinberg with
Moyamoya patient 1993
Dr. Steinberg with the
same Moyamoya patient 2004

Symptoms

Children typically have symptoms including:

Children also often experience temporary weakness in one or more of their extremities during strenuous physical activity or when crying. Adults can also present with brain hemorrhage causing neurologic symptoms in addition to nonhemorrhagic strokes, TIA's and headaches.

Moyamoya sometimes occurs along with other disorders such as Down's Syndrome, brain AVM's (arteriovenous malformations), and neurofibromatosis. We have also seen it in patients who had previous brain radiation for tumors.

Diagnosis

Based on the patients' symptoms and history, the physician may order one or all of these tests before making a decision about treatment.

strong>Magnetic Resonance Imaging (MRI)
This allows physicians to examine brain structures and detect any strokes that might have occurred. 

Moyamoya MRI with large stroke from Moyamoya MRI.
The arrows on this MRI of the brain shows a patient with a large stroke from moyamoya.


Cerebral Angiogram

This is the definitive test that confirms the diagnosis of moyamoya. "Contrast" (or dye) is injected into arteries to reveal the anatomy of the arteries of the brain and scalp. This is a minimally invasive test that requires patients to stay at the hospital for several hours. This test assesses the severity of moyamoya and its results guide treatment options, which are determined by how severe the disease is and what the external (scalp) blood supply is. 

Slide view of a normal angiogram.

MCA=middle cerebral artery
ACA=anterior cerebral artery
ICA=internal carotid artery
Angiogram of a patient with moyamoya disease. You can see the MCA and ACA vessels are imparied and moyamoya vessels have appeared along with other collateral vessels.



Xenon CT Scans

This test reveals blood flow to regions of the brain to determine if enough blood is reaching all areas. Patients breathe xenon (an odorless, colorless gas), which acts as a contrast agent to show regions of low and high blood flow.

Pre-Operative              Post Operative

Pre-Diamox Post-Diamox
Note the areas of red, which indicate a higher volume of blood flow to the brain when challenged with Diamox.

Resources

Stanford Medicine Resources:

Footer Links: